FDA Panel Recommends Pfizer/BioNTech Vaccine for 5 to 11-Year-Old Kids
Parents can expect a rollout of the vaccine in early November
The FDA’s expert panel, Vaccines, and Related Biological Products Advisory Committee that met yesterday, Oct. 26, has recommended that the agency issue an emergency use authorization (EUA) of the COVID-19 vaccine from Pfizer/BioNTech in young…